DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Anne Wojcicki - 2 23andMe - 2 Wojcicki - 2 Here's - 1 Anne - 1 New York CNN — - 1 ” Wojcicki - 1 “ - 1
Top related locs:
Austin , Texas New York Silicon Valley Los Angeles , California U.S London Sunnyvale , California United States
Top related orgs:
23andme Inc - 1 Southwest - 1 CNBC - 1 23andMe - 1 Board - 1 New - 1 New York CNN - 1 Nasdaq - 1

Search resuls for: "23andme Inc"


2 mentions found


☆ 23andMe CEO Anne Wojcicki 'surprised and disappointed' by board resignations: Read the memo
  + stars: | 2024-09-17 | by ( Ashley Capoot | In | ) www.cnbc.com   time to read: +3 min
All seven independent directors of 23andMe resigned from the company's board Tuesday, a move that CEO Anne Wojcicki said left her "surprised and disappointed," according to a memo to employees. Wojcicki, who co-founded 23andMe in 2006, said she remains committed to taking the company private. Wojcicki wrote in the employee memo, which was viewed by CNBC, that she still sees taking 23andMe private as its "best opportunity for long term success." The company will begin a search for new independent directors to join the board, she added. AnneWATCH: 23andMe CEO files to take company private
Persons: Anne Wojcicki, 23andMe, Wojcicki, Here's, Anne Organizations: 23andme Inc, Southwest, CNBC, 23andMe, Board Locations: Austin , Texas
☆ 23andMe is low on cash and its stock is worth pennies. The CEO wants another chance
  + stars: | 2024-02-02 | by ( Nicole Goodkind | ) edition.cnn.com   time to read: +8 min
New York CNN —Just three years ago, DNA testing company 23andMe was the golden child of Wall Street and Silicon Valley. In 2018, 23andMe agreed to a five-year exclusive drug development partnership with GSK (formerly GlaxoSmithKline). Genetic testing company 23andMe, once valued at $6 billion, is facing the possibility of delisting from NASDAQ. Justin Sullivan/Getty ImagesSo far, the partnership between GSK and 23andMe has produced more than 50 new drug targets. But drug discovery is a very long process and it can be anywhere from 10 to 15 years on average from target discovery to an FDA-approved drug.
Persons: New York CNN —, 23andMe, Anne Wojcicki, ” Wojcicki, “, Susan Wojcicki, Sergey Brin, Kyle Grillot, Wojcicki, they’ve, ”, we’re, “ We’ve, Steven Mah, TD Cowen, Mah, they’re, Justin Sullivan Organizations: New, New York CNN, Nasdaq, CNN, Stanford, Palo Alto High School, YouTube, Google, 23andMe Inc, Bloomberg, Time Magazine, P Biotech ETF, GSK, GlaxoSmithKline, NASDAQ, Big Pharma, it’s Locations: New York, Silicon Valley, Los Angeles , California, U.S, London, Sunnyvale , California, United States
0 next >>
Total: 2